NEW YORK (GenomeWeb) – Illumina expects its third quarter 2015 revenues to be lower than originally anticipated and has lowered its expected full-year revenue growth to 18 percent from its previous estimate of 20 percent, the company said after the close of the market today.

Illumina reported preliminary Q3 revenues of $550 million, a 14 percent increase from $481 million in the third quarter of 2014, but below analysts' average estimate of $568.6 million. On a constant currency basis, Q3 revenues were up 18 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.